Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607)
China
· Delayed Price · Currency is CNY 20.91
+0.20 (0.97%)
Nov 19, 2024, 3:00 PM CST
Shanghai Pharmaceuticals Holding Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 271,272 | 259,152 | 231,240 | 215,824 | 191,423 | 185,963 | Upgrade
|
| Other Revenue | 1,143 | 1,143 | 741.24 | - | 485.96 | 602.32 | Upgrade
|
| Revenue | 272,416 | 260,295 | 231,981 | 215,824 | 191,909 | 186,566 | Upgrade
|
| Revenue Growth (YoY) | 6.88% | 12.21% | 7.49% | 12.46% | 2.86% | 17.27% | Upgrade
|
| Cost of Revenue | 242,271 | 229,366 | 201,604 | 187,416 | 165,671 | 160,102 | Upgrade
|
| Gross Profit | 30,144 | 30,929 | 30,377 | 28,408 | 26,238 | 26,464 | Upgrade
|
| Selling, General & Admin | 18,485 | 19,527 | 19,173 | 18,376 | 16,797 | 17,449 | Upgrade
|
| Research & Development | 2,352 | 2,204 | 2,112 | 1,987 | 1,657 | 1,350 | Upgrade
|
| Other Operating Expenses | 514.9 | 376.86 | 654.72 | 633.18 | 587.25 | 380.36 | Upgrade
|
| Operating Expenses | 21,729 | 22,349 | 22,214 | 20,942 | 18,956 | 19,339 | Upgrade
|
| Operating Income | 8,415 | 8,581 | 8,164 | 7,466 | 7,282 | 7,124 | Upgrade
|
| Interest Expense | -1,810 | -1,885 | -1,689 | -1,518 | -1,412 | -1,405 | Upgrade
|
| Interest & Investment Income | 811.88 | 461.83 | 971.41 | 2,150 | 1,265 | 887.8 | Upgrade
|
| Currency Exchange Gain (Loss) | 11.41 | 11.41 | 21.51 | 10.1 | -41.43 | -16.14 | Upgrade
|
| Other Non Operating Income (Expenses) | -172.91 | -109.59 | -116.44 | -128.71 | -119.03 | -119.11 | Upgrade
|
| EBT Excluding Unusual Items | 7,255 | 7,059 | 7,351 | 7,979 | 6,974 | 6,471 | Upgrade
|
| Impairment of Goodwill | - | - | - | -19.21 | -486.27 | -704.76 | Upgrade
|
| Gain (Loss) on Sale of Investments | 142.94 | 155.93 | 218.74 | -206 | 116.8 | 122.16 | Upgrade
|
| Gain (Loss) on Sale of Assets | 133.72 | 92.48 | 1,439 | 58.29 | 52.15 | 71.34 | Upgrade
|
| Asset Writedown | -169.32 | -70.65 | -322.79 | -69.77 | -15.77 | -96.33 | Upgrade
|
| Legal Settlements | -12.69 | -12.69 | -37.38 | -8.1 | -34.82 | -1.82 | Upgrade
|
| Other Unusual Items | -169.95 | -169.95 | 160.13 | 409.61 | 569.14 | 400.4 | Upgrade
|
| Pretax Income | 7,180 | 7,054 | 8,808 | 8,144 | 7,175 | 6,262 | Upgrade
|
| Income Tax Expense | 1,944 | 1,888 | 1,816 | 1,869 | 1,570 | 1,432 | Upgrade
|
| Earnings From Continuing Operations | 5,236 | 5,167 | 6,992 | 6,275 | 5,605 | 4,831 | Upgrade
|
| Minority Interest in Earnings | -1,211 | -1,399 | -1,375 | -1,181 | -1,109 | -749.75 | Upgrade
|
| Net Income | 4,025 | 3,768 | 5,617 | 5,093 | 4,496 | 4,081 | Upgrade
|
| Net Income to Common | 4,025 | 3,768 | 5,617 | 5,093 | 4,496 | 4,081 | Upgrade
|
| Net Income Growth | -12.49% | -32.92% | 10.28% | 13.28% | 10.17% | 5.15% | Upgrade
|
| Shares Outstanding (Basic) | 3,726 | 3,701 | 3,483 | 2,842 | 2,842 | 2,842 | Upgrade
|
| Shares Outstanding (Diluted) | 3,726 | 3,701 | 3,483 | 2,842 | 2,842 | 2,842 | Upgrade
|
| Shares Change (YoY) | -0.83% | 6.28% | 22.54% | - | - | 0.45% | Upgrade
|
| EPS (Basic) | 1.08 | 1.02 | 1.61 | 1.79 | 1.58 | 1.44 | Upgrade
|
| EPS (Diluted) | 1.08 | 1.02 | 1.61 | 1.79 | 1.58 | 1.44 | Upgrade
|
| EPS Growth | -11.57% | -36.77% | -10.06% | 13.29% | 10.03% | 4.81% | Upgrade
|
| Free Cash Flow | 3,191 | 2,261 | 2,058 | 942.55 | 3,835 | 3,269 | Upgrade
|
| Free Cash Flow Per Share | 0.86 | 0.61 | 0.59 | 0.33 | 1.35 | 1.15 | Upgrade
|
| Dividend Per Share | 0.490 | 0.410 | 0.610 | 0.420 | 0.480 | 0.440 | Upgrade
|
| Dividend Growth | -19.67% | -32.79% | 45.24% | -12.50% | 9.09% | 7.32% | Upgrade
|
| Gross Margin | 11.07% | 11.88% | 13.09% | 13.16% | 13.67% | 14.18% | Upgrade
|
| Operating Margin | 3.09% | 3.30% | 3.52% | 3.46% | 3.79% | 3.82% | Upgrade
|
| Profit Margin | 1.48% | 1.45% | 2.42% | 2.36% | 2.34% | 2.19% | Upgrade
|
| Free Cash Flow Margin | 1.17% | 0.87% | 0.89% | 0.44% | 2.00% | 1.75% | Upgrade
|
| EBITDA | 9,618 | 9,922 | 9,689 | 8,973 | 8,779 | 8,454 | Upgrade
|
| EBITDA Margin | 3.53% | 3.81% | 4.18% | 4.16% | 4.57% | 4.53% | Upgrade
|
| D&A For EBITDA | 1,203 | 1,341 | 1,526 | 1,507 | 1,496 | 1,330 | Upgrade
|
| EBIT | 8,415 | 8,581 | 8,164 | 7,466 | 7,282 | 7,124 | Upgrade
|
| EBIT Margin | 3.09% | 3.30% | 3.52% | 3.46% | 3.79% | 3.82% | Upgrade
|
| Effective Tax Rate | 27.07% | 26.76% | 20.62% | 22.95% | 21.88% | 22.86% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.